Lipella pharmaceuticals initiates phase 2a trial for lp-310 in oral lichen planus, enrolls first patients

Top line data expected year-end 2024 pittsburgh, july 29, 2024 — lipella pharmaceuticals inc.

LIPO Ratings Summary

LIPO Quant Ranking